RT @KDAO2011: ICYMI: new guidelines published in 2019 for CV prevention. It's important to assess CV risk in our patients because inflamma…
RT @KDAO2011: ICYMI: new guidelines published in 2019 for CV prevention. It's important to assess CV risk in our patients because inflamma…
@DoctorTro As a learning exercise for myself, I went through the ACC/AHA 2019 Primary Prevention guidelines (https://t.co/IHXmHJYEXl). Here's all the Class III recommendations: https://t.co/mqEwFzx2Oc
Which grains you eat can impact your risk of getting heart disease earlier https://t.co/QQZdf20mzk https://t.co/I06vWDiKmf
Thanks @roseb_v for the link ("planet = plan it"). I'm stunned . . . and normotensive, out maneuvering demographics with plant based nutrition (https://t.co/K9oPiP9ggE) https://t.co/9OxiNVgBpr
@Conigman @PenelopeFigtree another good read https://t.co/Q5G2dynuYQ
RT @c_andersen_1: 12/ The 2019 ACC/AHA Primary Prevention Guidelines suggest ApoB measurement with TG levels ≥ 200 mg/dL. ➡ An ApoB level…
RT @c_andersen_1: 12/ The 2019 ACC/AHA Primary Prevention Guidelines suggest ApoB measurement with TG levels ≥ 200 mg/dL. ➡ An ApoB level…
RT @c_andersen_1: 12/ The 2019 ACC/AHA Primary Prevention Guidelines suggest ApoB measurement with TG levels ≥ 200 mg/dL. ➡ An ApoB level…
RT @c_andersen_1: 12/ The 2019 ACC/AHA Primary Prevention Guidelines suggest ApoB measurement with TG levels ≥ 200 mg/dL. ➡ An ApoB level…
RT @c_andersen_1: 12/ The 2019 ACC/AHA Primary Prevention Guidelines suggest ApoB measurement with TG levels ≥ 200 mg/dL. ➡ An ApoB level…
12/ The 2019 ACC/AHA Primary Prevention Guidelines suggest ApoB measurement with TG levels ≥ 200 mg/dL. ➡ An ApoB level ≥130 mg/dL corresponds to an LDL-C >160 mg/dL and constitutes a risk-enhancing factor. https://t.co/SEQ2Q4qEek https://t.co/s02Wff
@kaulcsmc In AHA/ACC guideline, #8 of top 10 take-home messages is: "Aspirin should be used infrequently in the routine primary prevention of ASCVD because of lack of net benefit." https://t.co/l15xgbkUEL
26) The primary prevention guidelines do allow use of #aspirin among select high #CV risk, low #bleeding risk patients (🔓https://t.co/6kE2UosGsQ) https://t.co/PJgsb8ZuRx
@Wolverfan @ScottAdamsSays Prior ‘19 guidance notes relevant studies. Funding is from a lot of different sources and your tax dollars https://t.co/a1PscpZ83u Most recent panel guidance comes with a boatload of links to studies prior findings https://t.c
@erreyedoc @VHellman10 @kevinnbass @BenBikmanPhD Would be better to teach the information in this new guideline paper from the European Cardiology Society https://t.co/Q5G2dyEy0Q
RT @KeithMugarura: Lifestyle changes and team based care in Primary Prevention of CVD #Cardiology #Cardiovascular #CardioEd #CardioTwitter…
Lifestyle changes and team based care in Primary Prevention of CVD #Cardiology #Cardiovascular #CardioEd #CardioTwitter #MedTwitter @JACCJournals https://t.co/O99r2aQoSt https://t.co/sufR8zdQYN
@RealKidPoker @quietwit @gearing1 Standard of care. Again, degrees in nutrition? Some but not all. Knowledge and counseling on proper diet for those with CVD with the latest evidenced based medicine recommendations? Yes https://t.co/DqsqNoU26o
@evo_lou @The_Nutrivore @kevinnbass And here are 3 different medical guidelines. Committees of people who all eat different diets. Read their dietary recommendations: https://t.co/CHIEizhuAW https://t.co/allHmee16Y https://t.co/33mLvtWynK
RT @jholtzman3: New in 2019, the ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease called for physicians to consider RI…
New in 2019, the ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease called for physicians to consider RISK-ENHANCING FACTORS specific to women. So what are some of these risk-enhancers? https://t.co/Utwt1HPdeU
RT @roomaan89: Impacto de las diferentes intervenciones dietéticas en pacientes hipertensos y normotensos. Fuente: https://t.co/9Af1IFIrxB…
RT @roomaan89: Impacto de las diferentes intervenciones dietéticas en pacientes hipertensos y normotensos. Fuente: https://t.co/9Af1IFIrxB…
RT @roomaan89: Impacto de las diferentes intervenciones dietéticas en pacientes hipertensos y normotensos. Fuente: https://t.co/9Af1IFIrxB…
Impacto de las diferentes intervenciones dietéticas en pacientes hipertensos y normotensos. Fuente: https://t.co/9Af1IFIrxB https://t.co/2HxoUZxmEp
RT @DBelardoMD: @MikeAlbertMD ACC has an entire committee that is elected to write the primary prevention guidelines, including @rblument1…
@ARadDocDates @babbymd Thanks!!
RT @DBelardoMD: @maxlugavere Everything I believe about nutrition at this time, can be summed up quite perfectly in the 2019 ACC guidelines…
RT @DBelardoMD: @maxlugavere Everything I believe about nutrition at this time, can be summed up quite perfectly in the 2019 ACC guidelines…
RT @DBelardoMD: @maxlugavere Everything I believe about nutrition at this time, can be summed up quite perfectly in the 2019 ACC guidelines…
@maxlugavere Everything I believe about nutrition at this time, can be summed up quite perfectly in the 2019 ACC guidelines, created by some of the most brilliant cardiologists in the world🙏 https://t.co/iR0HBakEdf https://t.co/buIjBzFBKn
RT @DBelardoMD: And can we apply the ACC/AHA 2019 primary prevention guidelines to heart failure patients? https://t.co/XHqjNcwkRR
And can we apply the ACC/AHA 2019 primary prevention guidelines to heart failure patients? https://t.co/XHqjNcwkRR
@FZores @DocAlban56 Quand tu regardes leurs guidelines de plus près, ils sont beaucoup moins enthousiastes... 🤷♂️ (pages e204->e206 : https://t.co/xMlhkGprwz)
RT @VietHeartPA: @postgradmed Updates on #Omega3? We discuss the evidence for adding #EPA/#IPE to your CV risk reduction toolkit. @omega360…
@postgradmed Updates on #Omega3? We discuss the evidence for adding #EPA/#IPE to your CV risk reduction toolkit. @omega360 @APAC_Cardiology @ASPCardio @Intermountain @RMUoHP https://t.co/8BZpJSxJNs 👆 #Ontheshouldersofgiants https://t.co/mLccChNNg1 #CVLip
@ScepticalDoctor @ACCinTouch Given that it is included in their most recent CVD primary prevention report, I'd say yes. https://t.co/yuRkNG6MFx
RT @DBelardoMD: @MikeAlbertMD ACC has an entire committee that is elected to write the primary prevention guidelines, including @rblument1…
RT @DBelardoMD: @MikeAlbertMD ACC has an entire committee that is elected to write the primary prevention guidelines, including @rblument1…
@MikeAlbertMD ACC has an entire committee that is elected to write the primary prevention guidelines, including @rblument1 @cardio10s @ErinMichos @boback and several others 😃 https://t.co/8EjeQ60YRp
RT @jsenior64: La guía completa. https://t.co/iqZAOk7Y0T
La guía completa. https://t.co/iqZAOk7Y0T
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: https://t.co/FT8kdGqU7G
RT @DrSubha58807116: Lifestyle management and early recognition of risk factor and control still remain the backbone of primary prevention.…
RT @mykel_d: #Aspirin no longer recommended for routine primary prevention of #ASCVD due to lack of net benefit. Ref: https://t.co/BXrFDosH…
Lifestyle management and early recognition of risk factor and control still remain the backbone of primary prevention. Nice one Dike.
RT @mykel_d: #Aspirin no longer recommended for routine primary prevention of #ASCVD due to lack of net benefit. Ref: https://t.co/BXrFDosH…
#Aspirin no longer recommended for routine primary prevention of #ASCVD due to lack of net benefit. Ref: https://t.co/BXrFDosHmM
RT @87HISHAM: 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease https://t.co/K79hNBJmcY
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease https://t.co/K79hNBJmcY
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease https://t.co/T9AcvdZ1YK
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease https://t.co/wELF7uxqiA
RT @PatologCritica: 2019 Ultimas Novedades, Actualizaciones y Modificaciones de las Guías de Práctica Clínica del American College of Cardi…
RT @PatologCritica: 2019 Ultimas Novedades, Actualizaciones y Modificaciones de las Guías de Práctica Clínica del American College of Cardi…
RT @PatologCritica: 2019 Ultimas Novedades, Actualizaciones y Modificaciones de las Guías de Práctica Clínica del American College of Cardi…
RT @PatologCritica: 2019 Ultimas Novedades, Actualizaciones y Modificaciones de las Guías de Práctica Clínica del American College of Cardi…
RT @PatologCritica: 2019 Ultimas Novedades, Actualizaciones y Modificaciones de las Guías de Práctica Clínica del American College of Cardi…
RT @PatologCritica: 2019 Ultimas Novedades, Actualizaciones y Modificaciones de las Guías de Práctica Clínica del American College of Cardi…
RT @PatologCritica: 2019 Ultimas Novedades, Actualizaciones y Modificaciones de las Guías de Práctica Clínica del American College of Cardi…
RT @PatologCritica: 2019 Ultimas Novedades, Actualizaciones y Modificaciones de las Guías de Práctica Clínica del American College of Cardi…
RT @PatologCritica: 2019 Ultimas Novedades, Actualizaciones y Modificaciones de las Guías de Práctica Clínica del American College of Cardi…
RT @PatologCritica: 2019 Ultimas Novedades, Actualizaciones y Modificaciones de las Guías de Práctica Clínica del American College of Cardi…
RT @PatologCritica: 2019 Ultimas Novedades, Actualizaciones y Modificaciones de las Guías de Práctica Clínica del American College of Cardi…
RT @PatologCritica: 2019 Ultimas Novedades, Actualizaciones y Modificaciones de las Guías de Práctica Clínica del American College of Cardi…
RT @PatologCritica: 2019 Ultimas Novedades, Actualizaciones y Modificaciones de las Guías de Práctica Clínica del American College of Cardi…
2019 Ultimas Novedades, Actualizaciones y Modificaciones de las Guías de Práctica Clínica del American College of Cardiology y la American Heart Association https://t.co/N19WhtfioT No te las pierdas!!! #ACC #AHA https://t.co/jcNbVC5EYx
RT @parraglaura: @Aroblesvalenti1 @BRoigEspert - Lípidos: año de guías. 🔸Prevención 1ª: https://t.co/GgKsPRTcD4 🔸Prevención 2ª: https://t.c…
@Aroblesvalenti1 @BRoigEspert - Lípidos: año de guías. 🔸Prevención 1ª: https://t.co/GgKsPRTcD4 🔸Prevención 2ª: https://t.co/XFD1ObMMT7 🔸iPCSK9 ¿cuándo?: https://t.co/yA3357X0NQ https://t.co/69tGrZrbLQ
RT @virgilioh: Bye-bye a la aspirina en prevención primaria (en mayores de 70 años y adultos con riesgo alto de sangrado) gracias a ARRIVE,…
RT @virgilioh: Bye-bye a la aspirina en prevención primaria (en mayores de 70 años y adultos con riesgo alto de sangrado) gracias a ARRIVE,…
RT @virgilioh: Bye-bye a la aspirina en prevención primaria (en mayores de 70 años y adultos con riesgo alto de sangrado) gracias a ARRIVE,…
RT @virgilioh: Bye-bye a la aspirina en prevención primaria (en mayores de 70 años y adultos con riesgo alto de sangrado) gracias a ARRIVE,…
RT @virgilioh: Bye-bye a la aspirina en prevención primaria (en mayores de 70 años y adultos con riesgo alto de sangrado) gracias a ARRIVE,…
RT @virgilioh: Bye-bye a la aspirina en prevención primaria (en mayores de 70 años y adultos con riesgo alto de sangrado) gracias a ARRIVE,…
RT @virgilioh: Bye-bye a la aspirina en prevención primaria (en mayores de 70 años y adultos con riesgo alto de sangrado) gracias a ARRIVE,…
RT @virgilioh: Bye-bye a la aspirina en prevención primaria (en mayores de 70 años y adultos con riesgo alto de sangrado) gracias a ARRIVE,…
RT @Julibturren: Ya vi que lo siguen dando... https://t.co/A3C8lzCtHj
RT @virgilioh: Bye-bye a la aspirina en prevención primaria (en mayores de 70 años y adultos con riesgo alto de sangrado) gracias a ARRIVE,…
RT @virgilioh: Bye-bye a la aspirina en prevención primaria (en mayores de 70 años y adultos con riesgo alto de sangrado) gracias a ARRIVE,…
Ya vi que lo siguen dando...
RT @virgilioh: Bye-bye a la aspirina en prevención primaria (en mayores de 70 años y adultos con riesgo alto de sangrado) gracias a ARRIVE,…
RT @virgilioh: Bye-bye a la aspirina en prevención primaria (en mayores de 70 años y adultos con riesgo alto de sangrado) gracias a ARRIVE,…